Guidance for Novavax, Inc. (NVAX)
| Period | Range | Estimate | Revenue Range | Revenue Estimate | Target | Details |
|---|---|---|---|---|---|---|
| 2024 | N/A | N/A | $0.80B – 1.00B | $0.97B | = Maintained | Details |
| 2023 | N/A | N/A | $1400.00M – 1600.00M | $831.06M | = Maintained | Details |
| 2022 | N/A | N/A | $4.00B – 5.00B | N/A | = Maintained | Details |
| 2022 | N/A | N/A | $4.00M – 5.00M | N/A | = Maintained | Details |
| 2022 | N/A | N/A | $2.00B – 2.30B | $4.27B |  Lowered |
Details |
| 2022 | N/A | N/A | $2.00B | $2.04B | Lowered |
Details |
| Q2 2018 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q1 2018 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q4 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q3 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q2 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q1 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
